SEC-sourced researchBeta
CLGN
CollPlant Biotechnologies Ltd
Company comparison ↗
Data passport
- CIK
- 0001631487
- Exchange
- Nasdaq
- Business activity
- Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
- Financial inputs
- 6/6
- Filing date
- Nov 12, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 10,959,000.0000 | Mar 26, 2026 |
| December 2024 | 515,000.0000 | Mar 26, 2026 |
| December 2025 | 2,371,000.0000 | Mar 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 2,371,000.0000 | -11,489,000.0000 | -9,419,000.0000 | 10,785,000.0000 | 4,704,000.0000 | Mar 26, 2026 |
| December 2024 | 515,000.0000 | -16,609,000.0000 | -14,093,000.0000 | 18,710,000.0000 | 5,245,000.0000 | Mar 26, 2026 |
| December 2023 | 10,959,000.0000 | -7,019,000.0000 | -2,763,000.0000 | — | — | Mar 26, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
51/100
Profitability0
Growth100
Balance sheet56
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $2.37M | Jan 1, 2025 – Dec 31, 2025 | Mar 26, 2026 | 20-F |
| Previous period revenueRevenues | $515K | Jan 1, 2024 – Dec 31, 2024 | Mar 26, 2026 | 20-F |
| Net incomeNetIncomeLoss | -$11.49M | Jan 1, 2025 – Dec 31, 2025 | Mar 26, 2026 | 20-F |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$9.42M | Jan 1, 2025 – Dec 31, 2025 | Mar 26, 2026 | 20-F |
| Total assetsAssets | $10.79M | Dec 31, 2025 | Mar 26, 2026 | 20-F |
| Total liabilitiesLiabilities | $4.7M | Dec 31, 2025 | Mar 26, 2026 | 20-F |
New filings
- 6-KCLGN · CollPlant Biotechnologies LtdNov 12, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdNov 12, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdNov 5, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdNov 4, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdNov 3, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdNov 2, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdOct 29, 2026 · Current event
- 144CLGN · CollPlant Biotechnologies LtdOct 27, 2026 · Other
- DCLGN · CollPlant Biotechnologies LtdOct 22, 2026 · Other
- 3CLGN · CollPlant Biotechnologies LtdOct 19, 2026 · Other
- 6-KCLGN · CollPlant Biotechnologies LtdOct 15, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdOct 9, 2026 · Current event
- SCHEDULE 13GCLGN · CollPlant Biotechnologies LtdOct 8, 2026 · Other
- SCHEDULE 13D/ACLGN · CollPlant Biotechnologies LtdOct 8, 2026 · Other
- 6-KCLGN · CollPlant Biotechnologies LtdOct 6, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdSep 30, 2026 · Current event
- 6-KCLGN · CollPlant Biotechnologies LtdSep 24, 2026 · Current event